Psoriatic Arthritis News and Research

RSS
Like rheumatoid arthritis (RA), psoriatic arthritis is a chronic inflammatory disease of the joints and connective tissue. The disease causes joint pain and swelling that can lead to crippling along with inflamed and irritated scaly red patches of skin throughout the body. It is a progressive and debilitating disease and because there are no treatments specifically approved for psoriatic arthritis, doctors often use therapies approved for RA, including nonsteroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). However, no DMARDs are currently approved for use in psoriatic arthritis. There are approximately 300,000 patients with psoriatic arthritis in the United States and the disease affects both men and women most commonly between the ages 30 and 50. Psoriatic arthritis patients are generally treated by rheumatologists and dermatologists.
Somatic mutation may act as a natural gene therapy in patients with rare autosomal disease

Somatic mutation may act as a natural gene therapy in patients with rare autosomal disease

Researchers launch clinical trial to assess therapeutic drug monitoring for patients with inflammatory diseases

Researchers launch clinical trial to assess therapeutic drug monitoring for patients with inflammatory diseases

People of color with rheumatic disease have worse COVID-19 outcomes

People of color with rheumatic disease have worse COVID-19 outcomes

Study shows low incidence of COVID-19 infection in people with rheumatic diseases

Study shows low incidence of COVID-19 infection in people with rheumatic diseases

Psoriatic arthritis may be activated by the same trigger in different patients, study reveals

Psoriatic arthritis may be activated by the same trigger in different patients, study reveals

Adults with rheumatoid arthritis have lower type 2 diabetes risk

Adults with rheumatoid arthritis have lower type 2 diabetes risk

High-resolution TB-PET/CT scanner reveals complete picture of systemic inflammatory arthritis

High-resolution TB-PET/CT scanner reveals complete picture of systemic inflammatory arthritis

National Psoriasis Foundation announces $3.28 million in research grants and fellowships

National Psoriasis Foundation announces $3.28 million in research grants and fellowships

Corrona Psoriasis Registry to present studies at AAD Virtual Meeting Experience

Corrona Psoriasis Registry to present studies at AAD Virtual Meeting Experience

Deployment of health care professionals can improve inflammatory-rheumatic disorders

Deployment of health care professionals can improve inflammatory-rheumatic disorders

Study uncovers link between psoriasis and joint disease

Study uncovers link between psoriasis and joint disease

Trial results show efficacy of netakimab for treating moderate-to-severe plaque psoriasis

Trial results show efficacy of netakimab for treating moderate-to-severe plaque psoriasis

EULAR publishes updated recommendations for treating people with psoriatic arthritis

EULAR publishes updated recommendations for treating people with psoriatic arthritis

Cancer risk in psoriatic patients

Cancer risk in psoriatic patients

Research project moves one step closer to personalized treatment of rheumatic diseases

Research project moves one step closer to personalized treatment of rheumatic diseases

Holistic Approaches to Psoriasis Treatment

Holistic Approaches to Psoriasis Treatment

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Age of psoriasis onset decides if the skin or joints act up first

Age of psoriasis onset decides if the skin or joints act up first

Methotrexate reduces joint damage in hand osteoarthritis

Methotrexate reduces joint damage in hand osteoarthritis

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis